Karyopharm Therapeutics | KPTI - EPS Earnings Per Share


Karyopharm Therapeutics reported $-1.02 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Abbott USD 0.53 0.78 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
MacroGenics USD 0.31 0.89 Jun/2026
Merck USD 2.49 2.62 Sep/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 2.46 0.05 Sep/2026
Novartis USD 0.63 1.36 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Takeda JPY 116.95 45.3 Sep/2026
Tectonic Therapeutic USD -1.18 0.17 Jun/2026
TG Therapeutics USD 0.35 0.3 Sep/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
Xencor USD 0.5 0.79 Sep/2026